University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Paul A. Volberding, MD, Director

Chief of Medical Service, San Francisco Veterans Affairs Medical Center

Professor and Vicechair, Department of Medicine; and Codirector, Center for AIDS Research; University of California San Francisco

Coeditor-in-Chief, Journal of Acquired Immune Deficiency Syndromes

Dr. Volberding is widely considered one of the world's leading AIDS experts. He cofounded one of the first AIDS-designated clinics in the early 1980s at San Francisco General Hospital. This clinic has evolved into the top-rated medical care facility for AIDS in the country. Dr. Volberding has served on numerous key national committees over the course of the epidemic, including the National Academy of Sciences (Institute of Medicine) AIDS Policy Review Steering Committee, National Institutes of Health (NIH) AIDS Drug Selection Committee, National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Executive Committee, Institute of Medicine Round Table, and the AIDS Clinical Trials Group Executive Committee. In 1990, Dr. Volberding cochaired the Sixth International Conference on AIDS, held in San Francisco, and served on the international advisory committees for all subsequent international conferences. He is currently chief of the medical service at the San Francisco Veterans Affairs Medical Center, and principal investigator and codirector of UCSF's Center for AIDS Research. Dr. Volberding has written numerous research and review articles. He is the coeditor-in-chief of the Journal of Acquired Immune Deficiency Syndromes, and is the founder and chair of the board of the International AIDS Society-USA. He is also the coeditor of The Medical Management of AIDS, the most widely used textbook of HIV medicine, now in its sixth edition. In 1999, he was elected to the Institute of Medicine of the National Academy of Sciences.

Statement of Financial Disclosure

Dr. Volberding serves as scientific advisor to Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Ortho Biotech, Pfizer/Agouron, Shire, and Schering; and on the speakers bureau for Gilead, GlaxoSmithKline, Ortho Biotech, and Schering.